TOUJEO is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Glargine.
| Product ID | 50090-2193_5e6a003a-854a-4097-8994-d35de2f2ec2a | 
| NDC | 50090-2193 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | TOUJEO | 
| Generic Name | Insulin Glargine | 
| Dosage Form | Injection, Solution | 
| Route of Administration | SUBCUTANEOUS | 
| Marketing Start Date | 2015-02-25 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206538 | 
| Labeler Name | A-S Medication Solutions | 
| Substance Name | INSULIN GLARGINE | 
| Active Ingredient Strength | 300 U/mL | 
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2015-10-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206538 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2015-10-26 | 
| Marketing End Date | 2019-01-31 | 
| Ingredient | Strength | 
|---|---|
| INSULIN GLARGINE | 300 U/mL | 
| SPL SET ID: | 257ca17b-6ff7-4f2e-9037-4c185bac5768 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0024-5869 | TOUJEO | insulin glargine | 
| 50090-2193 | TOUJEO | TOUJEO | 
| 0002-7715 | BASAGLAR | Insulin glargine | 
| 0002-8214 | BASAGLAR | Insulin glargine | 
| 0088-2220 | Lantus | insulin glargine | 
| 0088-2219 | Lantus Solostar | insulin glargine | 
| 0024-5871 | TOUJEO Max | insulin glargine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  TOUJEO  86327965  4939032 Live/Registered | Sanofi 2014-07-03 | 
|  TOUJEO  85835283  4469082 Live/Registered | Sanofi 2013-01-29 |